Please login to the form below

Not currently logged in


The Association of the British Pharmaceutical Industry has announced the launch of a new project in Nottingham to improve the treatment of chronic obstructive pulmonary disease
The Association of the British Pharmaceutical Industry (ABPI) has announced the launch of a new project in Nottingham to improve the treatment of chronic obstructive pulmonary disease (COPD).

Industry and Nottingham NHS Focus on Reducing COPD Exacerbations (INFORCE), is aimed at alleviating the burden on the health service created by the disease. It is a collaborative effort between Nottingham Primary Care Trust, Nottingham University Hospitals NHS Trust and five pharmaceutical companies operating under the banner of the ABPI NHS Outreach Programme.

"We all have a shared interest in improving people's health and reducing their need for hospital treatment," said Jan Balmer, regional facilitator for the ABPI. "The pharmaceutical industry is committed to working with the NHS throughout the UK to identify and develop similar opportunities where we can benefit patients by sharing our skills, experience and resources."

COPD affects approximately 3.7 million people in the UK and claims 140 lives every year in Nottingham alone. Although there are about 1,000 hospital admissions in the city per year, some of these are for repeat treatments.

It is hoped that INFORCE will reduce the number of people being admitted to hospital with COPD, the generic name for conditions, such as emphysema and chronic asthma, which cause obstruction of the airways.

"This is an excellent scheme which cuts across organisational boundaries to provide better care for patients," said Dr Johnathan Corne, consultant physician at Nottingham University Hospitals. "I am confident the outcomes of this scheme will help us to improve care of people with COPD and reduce the number of unnecessary admissions to hospital."

This is the second joint scheme the ABPI has embarked on in Nottingham, the first being Happy Hearts, a cardiovascular disease management project.

29th May 2008


Featured jobs

Subscribe to our email news alerts


Add my company

Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...

Latest intelligence

Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...